Latest Insider Transactions at Marinus Pharmaceuticals, Inc. (MRNS)
This section provides a real-time view of insider transactions for Marinus Pharmaceuticals, Inc. (MRNS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARINUS PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARINUS PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2022
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
12,867
+50.0%
|
-
|
|
Feb 04
2022
|
Timothy M Mayleben Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+16.54%
|
-
|
|
Feb 04
2022
|
Sara Nochur |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+50.0%
|
-
|
|
Feb 04
2022
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
16,550
+50.0%
|
-
|
|
Feb 04
2022
|
Nicole Vitullo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+29.92%
|
-
|
|
Mar 16
2021
|
Nicole Vitullo Director |
BUY
Other acquisition or disposition
|
Direct |
2,717
+42.39%
|
-
|
|
Mar 16
2021
|
Nicole Vitullo Director |
SELL
Other acquisition or disposition
|
Indirect |
17,804
-100.0%
|
-
|
|
Mar 15
2021
|
Nicole Vitullo Director |
SELL
Open market or private sale
|
Indirect |
4,250
-100.0%
|
$63,750
$15.87 P/Share
|
|
Mar 12
2021
|
Nicole Vitullo Director |
BUY
Other acquisition or disposition
|
Indirect |
6,192
+50.0%
|
-
|
|
Mar 12
2021
|
Nicole Vitullo Director |
SELL
Other acquisition or disposition
|
Indirect |
619,221
-100.0%
|
-
|
|
Mar 09
2021
|
Edward F Smith Former VP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
40,356
-75.23%
|
$686,052
$17.8 P/Share
|
|
Mar 09
2021
|
Edward F Smith Former VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
35,927
+40.11%
|
$143,708
$4.16 P/Share
|
|
Dec 19
2017
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
150,000
-1.83%
|
$1,050,000
$7.37 P/Share
|
|
Dec 18
2017
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
300,000
-6.78%
|
$2,100,000
$7.5 P/Share
|
|
Dec 15
2017
|
Bain Capital Life Sciences Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
822,547
-7.99%
|
$6,580,376
$8.33 P/Share
|